SAMSUNG PHARM. Co., Ltd.
001360.KS
Price:
$1600
Market Cap:
$150.59B
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, and others, as well as vitamins and energy drinks, and functional foods. The company was founded in 192...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-01-04
Stock Exchange
KSC
Ticker
001360.KS
PE Ratio
[-3.86]
ROE
[33.53%]
Current Ratio
[1.54]
Dividend Yield
[0%]
Enterprise Value
[152.17B]
Dividend History
The ROE as of December 2025 (TTM) for SAMSUNG PHARM. Co., Ltd. (001360.KS) is 33.53%
According to SAMSUNG PHARM. Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 33.53%. This represents a change of 468.08% compared to the average of 5.90% of the last 4 quarters.
SAMSUNG PHARM. Co., Ltd. (001360.KS) Historical ROE (quarterly & annually)
How has 001360.KS ROE performed in the past?
The mean historical ROE of SAMSUNG PHARM. Co., Ltd. over the last ten years is -16.73%. The current 33.53% ROE has changed -300.42% with respect to the historical average. Over the past ten years (40 quarters), 001360.KS's ROE was at its highest in in the June 2025 quarter at 30.71%. The ROE was at its lowest in in the December 2020 quarter at -17.12%.
Average
-16.73%
Median
-18.89%
Minimum
-32.71%
Maximum
4.82%
SAMSUNG PHARM. Co., Ltd. (001360.KS) ROE by Quarter and Year
Discovering the peaks and valleys of SAMSUNG PHARM. Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.12%
Maximum Annual ROE = 4.82%
Minimum Annual Increase = -778.53%
Minimum Annual ROE = -32.71%
| Year | ROE | Change |
|---|---|---|
| 2024 | -13.31% | -58.37% |
| 2023 | -31.98% | 30.75% |
| 2022 | -24.46% | -22.71% |
| 2021 | -31.65% | -3.25% |
| 2020 | -32.71% | -778.53% |
| 2019 | 4.82% | -405.77% |
| 2018 | -1.58% | -80.37% |
| 2017 | -8.03% | -69.39% |
| 2016 | -26.24% | 1.12% |
| 2015 | -2.15% | -97.89% |
SAMSUNG PHARM. Co., Ltd. (001360.KS) Average ROE
How has 001360.KS ROE performed in the past?
The current ROE of SAMSUNG PHARM. Co., Ltd. (001360.KS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.25%
5-year avg
-26.82%
10-year avg
-16.73%
SAMSUNG PHARM. Co., Ltd. (001360.KS) ROE vs. Peers
How is 001360.KS’s ROE compared to its peers?
SAMSUNG PHARM. Co., Ltd.’s ROE is greater than CKD Bio Corp. (-0.44%), greater than Enzychem Lifesciences Corporation (-13.95%), less than Kyongbo Pharmaceutical Co., Ltd (1.63%), less than Hana Pharm Co., Ltd. (4.13%), less than Ilsung Is Co., Ltd. (0.61%), less than Whan In Pharm Co.,Ltd. (3.98%), less than Dongwha Pharm.Co.,Ltd (2.03%), greater than HANDOK Inc. (-15.95%), greater than Jeil Pharma Holdings Inc (-9.48%), greater than Aprogen Biologics Inc. (-63.50%),
| Company | ROE | Market cap |
|---|---|---|
| -0.44% | $114.66B | |
| -13.95% | $122.31B | |
| 1.63% | $144.16B | |
| 4.13% | $203.96B | |
| 0.61% | $151.99B | |
| 3.98% | $177.25B | |
| 2.03% | $177.12B | |
| -15.95% | $156.34B | |
| -9.48% | $126.03B | |
| -63.50% | $115.38B |
Build a custom stock screener for SAMSUNG PHARM. Co., Ltd. (001360.KS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SAMSUNG PHARM. Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
SAMSUNG PHARM. Co., Ltd. (001360.KS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like SAMSUNG PHARM. Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is SAMSUNG PHARM. Co., Ltd.'s ROE?
How is the ROE calculated for SAMSUNG PHARM. Co., Ltd. (001360.KS)?
What is the highest ROE for SAMSUNG PHARM. Co., Ltd. (001360.KS)?
What is the 3-year average ROE for SAMSUNG PHARM. Co., Ltd. (001360.KS)?
What is the 5-year average ROE for SAMSUNG PHARM. Co., Ltd. (001360.KS)?
How does the current ROE for SAMSUNG PHARM. Co., Ltd. (001360.KS) compare to its historical average?